Pure Global
NCT06268522

Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)

Adjunctive Mindfulness During Opioid Tapering for Patients With Chronic Pain
Brigham and Women's Hospital·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Low Back Pain
Drug/Device/Intervention
Mindfulness-Oriented Recovery Enhancement: (MORE) group
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Brigham and Women's Hospital
Location
Chestnut Hill, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
Jun 01, 2024
Enrollment
200 participants
Primary outcome

Pain Interference,Opioid Dose

Summary

This study is a Randomized Controlled Trial exploring the effects of a Mindfulness
 interventions in reducing pain interference and opioid dose in patients with Chronic Low Back
 Pain. A total of 200 opioid-using patients with chronic pain, male and female participants
 will be enrolled, with a need for 160 completers. Patient will be randomly assigned into the
 Mindfulness-Oriented Recovery Enhancement or the Psychoeducation comparison control group.

ICD-10 classifications
Low back painPain in thoracic spineContusion of lower back and pelvisInjuries to the abdomen, lower back, lumbar spine and pelvisSprain and strain of lumbar spine
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06268522
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06268522 through Pure Global AI's free database. This phase not specified trial is sponsored by Brigham and Women's Hospital and is currently Recruiting. The study focuses on Low Back Pain. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.